Interstim Continence Control Therapy

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved September 1997

Specific Treatments:

urinary incontinence

Find Related Trials for The Following Conditions

General Information

Interstim Continence Control Therapy has been approved by the Food and Drug Administration (FDA). This is the first implantable treatment ever to use electrical stimulation of the sacral nerves to manage urinary urge incontinence. Depending on the patient, Interstim Continence Control Therapy can be used instead of, or in conjunction with, more conservative therapies, such as physical therapy, drug therapy and biofeedback.